Inquis Medical Raises $75M to Expand AVENTUS Thrombectomy
MENLO PARK, Calif., January 12, 2026 — Inquis Medical, a commercial-stage medical technology company focused on venous thromboembolic disease...
Capital for New Therapy
Parabilis Raises $305M to Advance First-in-Class Cancer Therapies
Cambridge, Massachusetts — January 8, 2026 — Parabilis Medicines announced the successful close of an oversubscribed $305 million Series...
Diagonal Therapeutics Secures $125M Series B to Advance Pipeline
CAMBRIDGE, Mass. | January 8, 2026 — Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibody therapies, announced the...
Johnson & Johnson Declares Q1 2026 Dividend, Signals Stability
NEW BRUNSWICK, NEW JERSEY | January 2, 2026 — Johnson & Johnson announced that its Board of Directors has...
Biobeat Raises $50M to Scale Cuff-less BP Monitoring
Petah Tikva, Israel & Boca Raton, Florida | December 30, 2025 — Biobeat Technologies Ltd. announced the successful closing...
Longeveron Joins Alzheimer’s Moonshot at JPM 2026
MIAMI, Fla., December 29, 2025 — Longeveron Inc., a clinical-stage biotechnology company developing regenerative cell therapies, has been selected...
Vyriad Secures $25M to Advance In Vivo CAR-T VV169
Rochester, Minnesota | December 23, 2025 — Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies, announced the...
Celularity Strengthens Platform With Strategic Financing Close
Florham Park, New Jersey | December 22, 2025 — Celularity Inc., a regenerative and cellular medicine company focused on...
Restart Life Secures Oversubscribed Financing to Advance Growth
Vancouver, British Columbia, December 18, 2025 — Restart Life Sciences Corp., a Canadian-based life sciences company, has successfully closed...
Moleculin Secures $6.8M to Support Clinical Development Plans
HOUSTON, Texas, Dec. 10, 2025 — Moleculin Biotech, a clinical-stage company developing novel oncology drug candidates including Annamycin for...